Memphasys Ltd
ASX:MEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Idun Industrier AB (publ)
STO:IDUN B
|
SE |
Memphasys Ltd
Operating Income
Memphasys Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Memphasys Ltd
ASX:MEM
|
Operating Income
-AU$3.9m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-5%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Operating Income
-AU$7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Operating Income
-AU$9.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Operating Income
AU$5.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Operating Income
AU$3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
28%
|
CAGR 10-Years
22%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Operating Income
AU$13.3m
|
CAGR 3-Years
60%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Memphasys Ltd
Glance View
Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.
See Also
What is Memphasys Ltd's Operating Income?
Operating Income
-3.9m
AUD
Based on the financial report for Dec 31, 2025, Memphasys Ltd's Operating Income amounts to -3.9m AUD.
What is Memphasys Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-5%
Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for Memphasys Ltd have been -40% over the past three years , -30% over the past five years , and -5% over the past ten years .
